A few reports have additionally given truly necessary understanding into the malicious effect that select treatments (counting cyclo-oxygenase-2-specific inhibitors) may have as far as the danger of cardiovascular illness in SLE [54]. Here, PTGS2 is linked to systemic lupus erythematosus.